Drugs

Copay Assist Programs Do Not Curb Drug Costs

Copay Assist Programs Do Not Curb Drug Costs

Despite offering assistance to those who cannot afford medications, programs create broader problems.

The Abuse Potential of Modafinil

The Abuse Potential of Modafinil

By

In order clarify the abuse potential of modafinil, investigators characterized its psychostimulant profile by using mice.

Misuse and Abuse of Gabapentin

Misuse and Abuse of Gabapentin

By

Researchers at ARIA Diagnostics in Indianapolis, IN conducted urine screens to test for opiates/opiods, gabapentin, pregabalin, and other substances.

Augmentation With Antidepressants in Schizophrenia Treatment Appears Safe and Efficacious

Augmentation With Antidepressants in Schizophrenia Treatment Appears Safe and Efficacious

By

In terms of depressive and negative symptoms, in the present meta-analysis, researchers estimate that 1 in 9 patients with schizophrenia will improve with add-on antidepressants.

FDA 'Breakthrough' Drug Designation Can Mislead Doctors

FDA 'Breakthrough' Drug Designation Can Mislead Doctors

Many believe that medications labelled "breakthrough" are supported by stronger evidence than the law requires for them to achieve that designation.

Sign Up for Free e-newsletters